Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Alcolea

Showing results (41-50 of 241) with videos related to

Pageof 25
Sort By:
Alzheimer'S Research & Therapy|November 3, 2022
Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer's disease patientsMatthew Paul Lennol, Irene Sánchez-Domínguez, Inmaculada Cuchillo-Ibañez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisNatalia Valle-Tamayo, Esther Álvarez-Sánchez, Laia Muñoz, et al.
Oncotarget|November 10, 2018
Obesity and Alzheimer's disease, does the obesity paradox really exist? A magnetic resonance imaging studyJordi Pegueroles, Amanda Jiménez, Eduard Vilaplana, et al.
Alzheimer'S Research & Therapy|July 27, 2024
Correction: Diagnostic performance of plasma pTau<sub>217</sub>, pTau<sub>181</sub>, Aβ<sub>1‑42</sub> and Aβ<sub>1‑40</sub> in the LUMIPULSE automated platform for the detection of Alzheimer diseaseJavier Arranz, Nuole Zhu, Sara Rubio-Guerra, et al.
Alzheimer'S Research & Therapy|June 26, 2024
Diagnostic performance of plasma pTau<sub>217</sub>, pTau<sub>181</sub>, Aβ<sub>1-42</sub> and Aβ<sub>1-40</sub> in the LUMIPULSE automated platform for the detection of Alzheimer diseaseJavier Arranz, Nuole Zhu, Sara Rubio-Guerra, et al.
Research Square|January 3, 2024
Diagnostic performance of plasma pTau 217, pTau 181, Aβ 1-42 and Aβ 1-40 in the LUMIPULSE automated platform for the detection of Alzheimer diseaseJavier Arranz, Nuole Zhu, Sara Rubio-Guerra, et al.
Clinical Chemistry and Laboratory Medicine|April 21, 2023
Effects of storage conditions on the stability of blood-based markers for the diagnosis of Alzheimer's diseaseAndrea Mansilla, Marina Canyelles, Rosa Ferrer, et al.
Neurobiology of Aging|January 17, 2017
Cerebrospinal fluid mitochondrial DNA in the Alzheimer's disease continuumLaura Cervera-Carles, Daniel Alcolea, Ainara Estanga, et al.
Annals of Neurology|May 24, 2014
Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer diseaseJuan Fortea, Eduard Vilaplana, Daniel Alcolea, et al.
Journal of Alzheimer'S Disease : JAD|April 5, 2021
Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal FluidGustaf Boström, Eva Freyhult, Johan Virhammar, et al.
Pageof 25

Showing results (41-50 of 241) with videos related to

Sort By:
Pageof 25
Alzheimer'S Research & Therapy|November 3, 2022
Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer's disease patientsMatthew Paul Lennol, Irene Sánchez-Domínguez, Inmaculada Cuchillo-Ibañez, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Basic Science and PathogenesisNatalia Valle-Tamayo, Esther Álvarez-Sánchez, Laia Muñoz, et al.
Oncotarget|November 10, 2018
Obesity and Alzheimer's disease, does the obesity paradox really exist? A magnetic resonance imaging studyJordi Pegueroles, Amanda Jiménez, Eduard Vilaplana, et al.
Alzheimer'S Research & Therapy|July 27, 2024
Correction: Diagnostic performance of plasma pTau<sub>217</sub>, pTau<sub>181</sub>, Aβ<sub>1‑42</sub> and Aβ<sub>1‑40</sub> in the LUMIPULSE automated platform for the detection of Alzheimer diseaseJavier Arranz, Nuole Zhu, Sara Rubio-Guerra, et al.
Alzheimer'S Research & Therapy|June 26, 2024
Diagnostic performance of plasma pTau<sub>217</sub>, pTau<sub>181</sub>, Aβ<sub>1-42</sub> and Aβ<sub>1-40</sub> in the LUMIPULSE automated platform for the detection of Alzheimer diseaseJavier Arranz, Nuole Zhu, Sara Rubio-Guerra, et al.
Research Square|January 3, 2024
Diagnostic performance of plasma pTau 217, pTau 181, Aβ 1-42 and Aβ 1-40 in the LUMIPULSE automated platform for the detection of Alzheimer diseaseJavier Arranz, Nuole Zhu, Sara Rubio-Guerra, et al.
Clinical Chemistry and Laboratory Medicine|April 21, 2023
Effects of storage conditions on the stability of blood-based markers for the diagnosis of Alzheimer's diseaseAndrea Mansilla, Marina Canyelles, Rosa Ferrer, et al.
Neurobiology of Aging|January 17, 2017
Cerebrospinal fluid mitochondrial DNA in the Alzheimer's disease continuumLaura Cervera-Carles, Daniel Alcolea, Ainara Estanga, et al.
Annals of Neurology|May 24, 2014
Cerebrospinal fluid β-amyloid and phospho-tau biomarker interactions affecting brain structure in preclinical Alzheimer diseaseJuan Fortea, Eduard Vilaplana, Daniel Alcolea, et al.
Journal of Alzheimer'S Disease : JAD|April 5, 2021
Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal FluidGustaf Boström, Eva Freyhult, Johan Virhammar, et al.
Pageof 25